Market Size in 2024 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 7.98 Billion | USD 14.36 Billion | 6.74% | 2023 |
The global cardiovascular devices market size was evaluated at $7.98 billion in 2023 and is slated to hit $14.36 billion by the end of 2032 with a CAGR of nearly 6.74% between 2024 and 2032.
The study includes drivers and restraints for the cardiovascular devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cardiovascular devices market on a global as well as regional level.
In order to give the users of this report a comprehensive view of the cardiovascular devices market, we have included a competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the device type segment is benchmarked based on their market size, growth rate, and general attractiveness.
The report provides a company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new device launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
Cardiovascular devices are portable devices generally used for the purpose of therapeutics and for treating heart-related disorders like cardiac arrhythmias, CCF, hypertension, myocardial infarction, etc. Cardiovascular diseases include congestive heart failure, arrhythmia, cardiomyopathy, congenital heart disease, hypertension, heart infections, coronary heart disease, valvular diseases, and myocardial infarction. The procedures involved in the treatment of cardiovascular problems are transmyocardial revascularization surgery, cardiac resynchronization therapy, coronary artery bypass surgery, heart transplantation, heart surgery, balloon valvuloplasty, valve replacement, and renal denervation surgery. Cardiovascular devices are showing continuous growth in terms of performance, characteristics, and features because of the continuous investment in the research and development by the healthcare industry to enhance the quality of the device.
As per the World Health Organization, cardiovascular diseases are the primary cause of death worldwide. About 17.5 million people died from cardiovascular diseases in 2015 representing 31% of all global deaths. Also, the global burden of cardiovascular disease is increasing owing to the growing geriatric population base across the world. Thus, the cardiovascular device market has vast potential owing to the large patient pool and an upsurge in the need for devices dealing with cardiovascular diseases.
Furthermore, the increase in consumption of junk food and a decline in the physical activities of people has resulted in the increase of cardiovascular diseases. However, high cost, complex development procedure, and handling techniques are the major restraints that may limit the growth of the market. Nevertheless, high investment in research & development to launch new and advanced cardiovascular devices with minimum side effects along with increasing adoption of remote patient monitoring and telemedicine is propelling the demand for cardiovascular devices market within the forecast period.
The study provides a decisive view of the cardiovascular devices market by segmenting the market based on device type and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024.
Based on device type, the cardiovascular devices market is categorized as cardiac diagnostics & monitoring devices, electrophysiology devices, peripheral vascular devices, interventional cardiac devices, cardiac rhythm management, cardiac prosthetic devices, and others. Cardiac diagnostic and monitoring devices are estimated to cover the largest market value share due to the compact and portable designs of ECG devices along with data storage properties.
Report Attributes | Report Details |
---|---|
Report Name | Cardiovascular Devices Market Research Report |
Market Size in 2024 | USD 7.98 Billion |
Market Forecast in 2032 | USD 14.36 Billion |
Growth Rate | CAGR of 6.74% |
Number of Pages | 215 |
Key Companies Covered | Aboimed, Inc., Abbott Vascular, Biotronik SE & Co. KG, B. Braun Melsungen AG, Cardinal Health Inc., Boston Scientific Corporation, Cook Medical, Inc., Cordis Corporation, GE Healthcare, JOHNSON & JOHNSON, and others. |
Segments Covered | By Device Type, and By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for cardiovascular devices based on individual segments and applications in all regions and countries.
North America is anticipated to dominate the market in terms of value share in the forecast period. Developed healthcare infrastructure, favorable government policies, and research grant provided by the government and ruling authorities are expected to boost the market in this region. Europe is covering the second largest market value share in the cardiovascular device market followed by the Asia Pacific. The Asia Pacific is likely to grow at a high CAGR during the forecast period while Latin America market is projected to grow at a moderate rate. Large population base in the Asia Pacific region, especially in India, China, and Japan are the driving factors for the growth of the cardiovascular device market in this region. The Middle East and Africa are also expected to experience noticeable growth in the years to come.
The report also includes detailed profiles of end players such as Aboimed, Inc., Abbott Vascular, Biotronik SE & Co. KG, B. Braun Melsungen AG, Cardinal Health Inc., Boston Scientific Corporation, Cook Medical, Inc., Cordis Corporation, GE Healthcare, JOHNSON & JOHNSON, and others.
The global dardiovascular devices market profiles key players such as:
Cardiovascular Devices Market: By Device Type
Percutaneous Transluminal Coronary Angioplasty (PTCA) Guidewires
Cardiac Prosthetic Devices
Global Cardiovascular Devices Market: By Region
FrequentlyAsked Questions
Medical devices intended for the diagnosis, monitoring, and treatment of conditions affecting the cardiovascular system, comprising the heart and blood vessels, are referred to as cardiovascular devices. These devices are of the utmost importance in the management of numerous cardiovascular diseases and disorders. Therapeutic interventions, diagnostic support, and overall cardiovascular system functionality are all possible with cardiovascular devices.
The increasing incidence of cardiovascular ailments, including arrhythmias, heart failure, and coronary artery disease, is a substantial factor propelling the cardiovascular devices market. The anticipated increase in lifestyle modifications and the aging of the global population will drive demand for cardiovascular devices utilized in diagnosis and treatment.
The global cardiovascular devices market size was evaluated at $7.98 billion in 2023 and is slated to hit $14.36 billion by the end of 2032.
The global cardiovascular devices market with a CAGR of nearly 6.74% between 2024 and 2032.
Regional segmentation comprises present and projected demand for the following regions: North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. This is further subdivided into demand for the following main countries: the United States, Germany, France, United Kingdom, China, Japan, India, and Brazil. Demand for cardiovascular devices is segmented according to specific applications and segments across all countries and regions.
The report also includes detailed profiles of end players such as Aboimed, Inc., Abbott Vascular, Biotronik SE & Co. KG, B. Braun Melsungen AG, Cardinal Health Inc., Boston Scientific Corporation, Cook Medical, Inc., Cordis Corporation, GE Healthcare, JOHNSON & JOHNSON, and others.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed